Form 4: IN8BIO Director Acquires Stock Options
SEC Form 4 Filing
Director Jeremy R. Graff acquires stock options in IN8BIO, INC.
Summary
- On December 19, 2024, Jeremy R. Graff, a director of IN8BIO, INC., acquired 47,697 stock options with an exercise price of $0.24.
- These options vest on December 19, 2025, contingent upon continued service.
- Following the transaction, Graff directly owns 47,697 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard disclosure of stock option acquisition. The director's confidence is a slight positive, but it's not a major event.
Positives
- The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director could have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/19/2024 | Date of stock option acquisition |
| 12/19/2025 | Vesting date of the stock options |
| 12/19/2034 | Expiration date of the stock options |
| 12/23/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.